Literature DB >> 28405113

A New Dawn for Intrauterine Insemination: Efficient and Prudent Practice will Benefit Patients, the Fertility Industry and the Healthcare Bodies.

Gulam Bahadur1,2,3, Roy Homburg2, Ansam Al-Habib1.   

Abstract

This review addresses the misplaced facts about the IUI procedure within a lucrative fertility industry. Evidence suggests IUI must be a first-line treatment option for most couples except in cases of bilateral tubal blockage and severe oligozoospermia. We introduce the concept of using 'consecutive ejaculation' in men with subfertility and one which can radically alter the male infertility definition, thereby providing a new approach to examining and managing male factor infertility. The review also explores various aspects affecting the IUI procedure, its determinants of success, risks and areas for future improvements. Areas such as choice of patients, clinical management of patients, the type of stimulation regime, timing and the management of sperm usage have significant bearing to whether IUI will succeed. The paper asserts that IUI should be the first choice of fertility treatment.

Entities:  

Keywords:  Bifollicular; Clomiphene; Cost-effectiveness; Expectant management; GnRH; IUI; IVF; Male factor; Pregnancy rates; Unifollicular

Year:  2016        PMID: 28405113      PMCID: PMC5371520          DOI: 10.1007/s13224-016-0928-5

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  50 in total

Review 1.  Review: aromatase inhibitors for ovulation induction.

Authors:  Robert F Casper; Mohamed F M Mitwally
Journal:  J Clin Endocrinol Metab       Date:  2005-12-29       Impact factor: 5.958

Review 2.  Semen preparation techniques for intrauterine insemination.

Authors:  C M Boomsma; M J Heineman; B J Cohlen; C Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 3.  The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis.

Authors:  M M E van Rumste; I M Custers; F van der Veen; M van Wely; J L H Evers; B W J Mol
Journal:  Hum Reprod Update       Date:  2008-08-06       Impact factor: 15.610

4.  Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success.

Authors:  M J Tomlinson; J B Amissah-Arthur; K A Thompson; J L Kasraie; B Bentick
Journal:  Hum Reprod       Date:  1996-09       Impact factor: 6.918

Review 5.  Aromatase inhibitors for subfertile women with polycystic ovary syndrome.

Authors:  Sebastian Franik; Jan A M Kremer; Willianne L D M Nelen; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2014-02-24

6.  Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial.

Authors:  Pieternel Steures; Jan Willem van der Steeg; Peter G A Hompes; J Dik F Habbema; Marinus J C Eijkemans; Frank J Broekmans; Harold R Verhoeve; Patrick M M Bossuyt; Fulco van der Veen; Ben W J Mol
Journal:  Lancet       Date:  2006-07-15       Impact factor: 79.321

7.  Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles.

Authors:  Richard P Dickey; Steven N Taylor; Peter Y Lu; Belinda M Sartor; Phillip H Rye; Roman Pyrzak
Journal:  Fertil Steril       Date:  2005-03       Impact factor: 7.329

8.  Homologous intrauterine insemination. An evaluation of prognostic factors based on a review of 2473 cycles.

Authors:  M R Khalil; P E Rasmussen; K Erb; S B Laursen; S Rex; L G Westergaard
Journal:  Acta Obstet Gynecol Scand       Date:  2001-01       Impact factor: 3.636

Review 9.  Clomiphene citrate for unexplained subfertility in women.

Authors:  Edward Hughes; Julie Brown; John J Collins; Patrick Vanderkerchove
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

10.  Does optimal follicular size in IUI cycles vary between clomiphene citrate and gonadotrophins treatments?

Authors:  Einat Shalom-Paz; Alicia Marzal; Amir Wiser; Jordana Hyman; Togas Tulandi
Journal:  Gynecol Endocrinol       Date:  2013-11-22       Impact factor: 2.260

View more
  5 in total

1.  Reappraisal of clinical data supports double IUI for improved pregnancy outcomes.

Authors:  G Bahadur; R Homburg
Journal:  Facts Views Vis Obgyn       Date:  2018-03

2.  Pregnancy rates after slow-release insemination (SRI) and standard bolus intrauterine insemination (IUI) - A multicentre randomised, controlled trial.

Authors:  Julian Marschalek; Christian Egarter; Elisabeth Vytiska-Binsdorfer; Andreas Obruca; Jackie Campbell; Philip Harris; Maarten van Santen; Bernd Lesoine; Johannes Ott; Maximilian Franz
Journal:  Sci Rep       Date:  2020-05-07       Impact factor: 4.379

Review 3.  A review of conventional and sustained-release formulations of oral natural micronized progesterone in obstetric indications.

Authors:  Girija Narendrakumar Wagh; K M Kundavi Shankar; Sumitra Bachani
Journal:  Drugs Context       Date:  2021-10-13

4.  Clomiphene Citrate versus Recombinant FSH in intrauterine insemination cycles with mono- or bi-follicular development.

Authors:  Vehbi Yavuz Tokgoz; Yavuz Emre Sukur; Batuhan Ozmen; Murat Sonmezer; Bulent Berker; Rusen Aytac; Cem Somer Atabekoglu
Journal:  JBRA Assist Reprod       Date:  2021-07-21

Review 5.  Are Vitamin E Supplementation Beneficial for Female Gynaecology Health and Diseases?

Authors:  Nur Amira Md Amin; Siti Hamimah Sheikh Abdul Kadir; Akmal Hisyam Arshad; Norhaslinda Abdul Aziz; Nurul Alimah Abdul Nasir; Normala Ab Latip
Journal:  Molecules       Date:  2022-03-15       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.